New Research Claims Diabetes Drug Has Higher Risk Of Heart Disease

New research claims that sulphonylureas, a class of drugs used to treat Type 2 diabetes, carry a greater risk of heart failure and death compared with the diabetes drug metformin. A team of researchers from Imperial College London investigated the risk of heart attack, congestive heart failure and death from any cause associated with the prescription of different types of diabetes drugs...

This entry was posted on Thursday, December 10th, 2009 at 9:00 am and is filed under Diabetes, Diabets. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Leave a Reply

You must be logged in to post a comment.